Guidelines for Bacteriophage Product Certification (Q48606487)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2018

edit

Language	Label	Description	Also known as
English	Guidelines for Bacteriophage Product Certification	scientific article published in January 2018

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29119445

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/29119445

title

Guidelines for Bacteriophage Product Certification (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29119445

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/29119445

main subject

bacteriophage

1 reference

based on heuristic

inferred from title

author

Alan Fauconnier

series ordinal

1

object named as

Alan Fauconnier

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29119445

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/29119445

language of work or name

English

0 references

publication date

1 January 2018

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29119445

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/29119445

published in

Methods in Molecular Biology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29119445

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/29119445

volume

1693

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29119445

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/29119445

page(s)

253-268

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29119445

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/29119445

cites work

Phage cocktails and the future of phage therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_19

retrieved

21 January 2018

Paving a regulatory pathway for phage therapy. Europe should muster the resources to financially, technically and legally support the introduction of phage therapy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_19

retrieved

21 January 2018

Phage therapy pharmacology phage cocktails

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_19

retrieved

21 January 2018

European regulatory conundrum of phage therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_19

retrieved

21 January 2018

What are the limitations on the wider therapeutic use of phage?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_19

retrieved

21 January 2018

Call for a dedicated European legal framework for bacteriophage therapy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_19

retrieved

21 January 2018

Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_19

retrieved

21 January 2018

Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_19

retrieved

21 January 2018

Bacteriophage therapy: a regulatory perspective

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_19

retrieved

21 January 2018

Available Tools to Facilitate Early Patient Access to Medicines in the EU and the USA: Analysis of Conditional Approvals and the Implications for Personalized Medicine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_19

retrieved

21 January 2018

Proposal for new European pharmaceutical legislation to permit access to custom-made anti-sense oligonucleotide medicinal products

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_19

retrieved

21 January 2018

The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_19

retrieved

21 January 2018

Identifiers

DOI

10.1007/978-1-4939-7395-8_19

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29119445

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/29119445

PubMed publication ID

29119445

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29119445

retrieved

13 February 2018

reference URL

http://europepmc.org/abstract/MED/29119445

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48606487&oldid=2202957939"